Ceribell (CBLL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $25.04, -9.41% vs the prior close of $27.64.
- Volume 406.59K shares, 1.0x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CBLL slides 9.4% to $25.04. Closed at $25.04, -9.41% vs the prior close of $27.64. Day range $24.86–$27.48, opened at $27.48.
CBLL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CBLL slides 9.4% to $25.04
- Closed at $25.04, -9.41% vs the prior close of $27.64. Day range $24.86–$27.48, opened at $27.48.
- Volume was 406.59K shares, 1.0x its 50-day average of 407.80K.
- Price is +4.2% vs its 50-day average ($24.03) and +21.9% vs its 200-day average ($20.54).
- 52-week range $10.85–$27.94; today's close sits at 83% of that range, 10.4% below the 52-week high.
Oct 15, 2026 — CBLL jumps 4.8% to $27.64, a 52-week high on 2.3x normal volume
- Closed at $27.64, +4.82% vs the prior close of $26.37. Day range $25.85–$27.94, opened at $26.50.
- Volume was 911.80K shares, 2.3x its 50-day average of 393.19K — unusually heavy trading.
- Price is +15.7% vs its 50-day average ($23.90) and +34.7% vs its 200-day average ($20.53).
- 52-week range $10.85–$27.94; today's close sits at 98% of that range, 1.1% below the 52-week high.
- That makes 5 straight gains.
Oct 14, 2026 — CBLL rises 0.9% to $26.37, a 52-week high on 2.3x normal volume
- Closed at $26.37, +0.88% vs the prior close of $26.14. Day range $25.00–$26.72, opened at $25.78.
- Volume was 887.60K shares, 2.3x its 50-day average of 381.98K — unusually heavy trading.
- Price is +11.2% vs its 50-day average ($23.71) and +28.7% vs its 200-day average ($20.50).
- 52-week range $10.85–$26.72; today's close sits at 98% of that range, 1.3% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — CBLL jumps 3.5% to $26.14, a 52-week high, 3 up days in a row
- Closed at $26.14, +3.48% vs the prior close of $25.26. Day range $24.90–$26.62, opened at $25.35.
- Volume was 542.70K shares, 1.4x its 50-day average of 381.86K.
- Price is +11.0% vs its 50-day average ($23.55) and +27.7% vs its 200-day average ($20.47).
- 52-week range $10.85–$26.62; today's close sits at 97% of that range, 1.8% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — CBLL jumps 6.9% to $25.26, a 52-week high on 1.9x normal volume
- Closed at $25.26, +6.90% vs the prior close of $23.63. Day range $23.27–$25.27, opened at $23.77.
- Volume was 696.90K shares, 1.9x its 50-day average of 376.14K — unusually heavy trading.
- Price is +8.0% vs its 50-day average ($23.40) and +23.5% vs its 200-day average ($20.45).
- 52-week range $10.85–$25.63; today's close sits at 98% of that range, 1.4% below the 52-week high.
Oct 9, 2026 — CBLL rises 2.1% to $23.63
- Closed at $23.63, +2.07% vs the prior close of $23.15. Day range $22.90–$23.85, opened at $23.03.
- Volume was 325.30K shares, 0.9x its 50-day average of 377.38K.
- Price is +1.7% vs its 50-day average ($23.25) and +15.7% vs its 200-day average ($20.43).
- 52-week range $10.85–$25.63; today's close sits at 86% of that range, 7.8% below the 52-week high.
Oct 8, 2026 — CBLL dips 1.4% to $23.15, a 1-month low, 3 down days in a row
- Closed at $23.15, -1.41% vs the prior close of $23.48. Day range $22.62–$23.40, opened at $23.40.
- Volume was 243.80K shares, 0.6x its 50-day average of 377.97K.
- Price is +0.1% vs its 50-day average ($23.13) and +13.4% vs its 200-day average ($20.41).
- 52-week range $10.85–$25.63; today's close sits at 83% of that range, 9.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CBLL slides 3.5% to $23.48
- Closed at $23.48, -3.53% vs the prior close of $24.34. Day range $23.43–$24.55, opened at $24.20.
- Volume was 305.40K shares, 0.8x its 50-day average of 378.09K.
- Price is +2.0% vs its 50-day average ($23.02) and +15.1% vs its 200-day average ($20.40).
- 52-week range $10.85–$25.63; today's close sits at 85% of that range, 8.4% below the 52-week high.
Oct 6, 2026 — CBLL dips 2.1% to $24.34
- Closed at $24.34, -2.09% vs the prior close of $24.86. Day range $24.22–$25.10, opened at $24.95.
- Volume was 241.70K shares, 0.6x its 50-day average of 382.10K.
- Price is +6.3% vs its 50-day average ($22.90) and +19.4% vs its 200-day average ($20.39).
- 52-week range $10.85–$25.63; today's close sits at 91% of that range, 5.0% below the 52-week high.
Oct 5, 2026 — CBLL jumps 4.9% to $24.86
- Closed at $24.86, +4.94% vs the prior close of $23.69. Day range $23.67–$25.05, opened at $23.67.
- Volume was 239.50K shares, 0.6x its 50-day average of 384.58K.
- Price is +9.1% vs its 50-day average ($22.78) and +22.0% vs its 200-day average ($20.38).
- 52-week range $10.85–$25.63; today's close sits at 95% of that range, 3.0% below the 52-week high.
Oct 2, 2026 — CBLL rises 0.3% to $23.69
- Closed at $23.69, +0.34% vs the prior close of $23.61. Day range $23.32–$24.19, opened at $24.18.
- Volume was 307.00K shares, 0.8x its 50-day average of 386.57K.
- Price is +4.7% vs its 50-day average ($22.62) and +16.3% vs its 200-day average ($20.37).
- 52-week range $10.85–$25.63; today's close sits at 87% of that range, 7.6% below the 52-week high.
CBLL latest news & SEC filings
Every SEC filing by or about CBLL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Woo Raymond converted options/RSUs into 4,864 shares at $3.65 (≈$17.75K) on Oct 1, 2026; now holds 207,982
- Woo Raymond converted options/RSUs into 23 shares at $4.70 (≈$108) on Oct 1, 2026; now holds 208,005
- Woo Raymond sold 4,887 shares at $24.38 (≈$119.15K) on Oct 1, 2026; now holds 203,118
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chao Xingjuan sold 20,846 shares at $25.03 (≈$521.78K) on Sep 15, 2026; now holds 746,345
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Blumberg Scott converted options/RSUs into 846 shares at $9.41 (≈$7.96K) on Sep 15, 2026; now holds 147,446
- Blumberg Scott sold 846 shares at $25.00 (≈$21.15K) on Sep 15, 2026; now holds 146,600
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $28.10M (prior year $21.20M) (+32.5% vs Jun 30, 2025)
- Net income: -$19.27M (prior year -$13.64M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.51 (prior year -$0.38) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CBLL
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Feb 24, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.72% (largest 9.4%).
- Liquidity: about 388.87K shares (≈$9.74M) trade per day on average.
- 52-week position: $25.04 vs a range of $10.85–$27.94 (83% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Xingjuan Chao sold 20,846 shares on Sep 15, 2026.
- Latest filings: 10-Q Aug 10, 2026; 8-K Aug 10, 2026; 8-K Jul 30, 2026.
- Share count: 38.38M shares outstanding (Aug 6, 2026), +4.7% vs a year earlier.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
CBLL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 27.48 | 27.48 | 24.86 | 25.04 | 406.59K |
| Oct 15, 2026 | 26.50 | 27.94 | 25.85 | 27.64 | 911.80K |
| Oct 14, 2026 | 25.78 | 26.72 | 25.00 | 26.37 | 887.60K |
| Oct 13, 2026 | 25.35 | 26.62 | 24.90 | 26.14 | 542.70K |
| Oct 12, 2026 | 23.77 | 25.27 | 23.27 | 25.26 | 696.90K |
| Oct 9, 2026 | 23.03 | 23.85 | 22.90 | 23.63 | 325.30K |
| Oct 8, 2026 | 23.40 | 23.40 | 22.62 | 23.15 | 243.80K |
| Oct 7, 2026 | 24.20 | 24.55 | 23.43 | 23.48 | 305.40K |
| Oct 6, 2026 | 24.95 | 25.10 | 24.22 | 24.34 | 241.70K |
| Oct 5, 2026 | 23.67 | 25.05 | 23.67 | 24.86 | 239.50K |
| Oct 2, 2026 | 24.18 | 24.19 | 23.32 | 23.69 | 307.00K |
| Oct 1, 2026 | 24.38 | 24.54 | 23.50 | 23.61 | 316.70K |
| Sep 30, 2026 | 25.00 | 25.25 | 24.36 | 24.39 | 336.10K |
| Sep 29, 2026 | 24.51 | 24.90 | 24.03 | 24.86 | 300.90K |
| Sep 28, 2026 | 23.61 | 24.59 | 23.52 | 24.51 | 216.70K |
| Sep 25, 2026 | 23.87 | 23.88 | 23.38 | 23.69 | 270.60K |
| Sep 24, 2026 | 23.62 | 23.90 | 23.19 | 23.82 | 215.10K |
| Sep 23, 2026 | 24.08 | 24.22 | 23.33 | 23.62 | 353.80K |
| Sep 22, 2026 | 24.47 | 24.68 | 24.11 | 24.25 | 349.80K |
| Sep 21, 2026 | 24.51 | 24.66 | 24.00 | 24.25 | 309.40K |
About Ceribell
Ceribell (CBLL) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in SUNNYVALE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1861107.
CBLL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William W Burke | Director | Jul 2, 2026 |
| Xingjuan Chao | President and CEO | Sep 17, 2026 |
| Sharon O'Keefe | Director | Jul 30, 2026 |
| Josef Parvizi | Director | Jun 4, 2026 |
| Rebecca B Robertson | Director | Jun 4, 2026 |
| Erica J. Rogers | Director | Jun 4, 2026 |
| Bakker Juliet Tammenoms | Director | Jun 4, 2026 |
| Joseph Michael Taylor | Director | Aug 14, 2026 |
| Thomas A. West | Director | Jul 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Scott Blumberg | Chief Financial Officer | Sep 17, 2026 |
| Xingjuan Chao | President and CEO | Sep 17, 2026 |
| David Foehr | Senior VP, Finance and PAO | Sep 10, 2026 |
| Joseph S. Manni | Chief Revenue Officer | Aug 25, 2026 |
| Raymond Woo | Chief Technology Officer | Sep 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Xingjuan Chao | Sale | 20,846 | $25.03 |
| Sep 15, 2026 | Xingjuan Chao | Sale | 20,846 | $25.03 |
| Sep 15, 2026 | Xingjuan Chao | Sale | 20,846 | $25.03 |
| Sep 15, 2026 | Xingjuan Chao | Sale | 20,846 | $25.03 |
| Sep 15, 2026 | Scott Blumberg | Sale | 846 | $25.00 |
| Sep 15, 2026 | Scott Blumberg | Sale | 846 | $25.00 |
| Sep 15, 2026 | Scott Blumberg | Sale | 846 | $25.00 |
| Sep 15, 2026 | Scott Blumberg | Sale | 846 | $25.00 |
| Sep 8, 2026 | Raymond Woo | Sale | 4,887 | $24.33 |
| Sep 8, 2026 | Raymond Woo | Sale | 4,887 | $24.33 |
| Sep 8, 2026 | Raymond Woo | Sale | 4,887 | $24.33 |
| Sep 8, 2026 | Raymond Woo | Sale | 4,887 | $24.33 |
| Sep 8, 2026 | David Foehr | Sale | 1,755 | $24.26 |
| Sep 8, 2026 | David Foehr | Sale | 7,500 | $24.25 |
| Sep 8, 2026 | David Foehr | Sale | 1,755 | $24.26 |
CBLL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $89.06M | $-53.41M | -1.46 | $-40.81M |
| Dec 31, 2024 | $65.44M | $-40.45M | -3.39 | $-35.04M |
| Dec 31, 2023 | $45.23M | $-29.46M | -5.56 | $-29.16M |
Latest balance sheet: total assets $166.35M, total liabilities $38.03M, cash $32.66M (as of Jun 30, 2026).
CBLL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $19.30 |
| May 11, 2026 | 8-K Item 2.02 (results) | $20.06 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $19.90 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $10.92 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $15.08 |
| May 8, 2025 | 8-K Item 2.02 (results) | $17.10 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $25.54 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $28.85 |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)InMode (INMD)Electromed (ELMD)Hyperfine (HYPR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CBLL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.